Market revenue in 2023 | USD 53.8 million |
Market revenue in 2030 | USD 110.1 million |
Growth rate | 10.8% (CAGR from 2023 to 2030) |
Largest segment | Human primary cells |
Fastest growing segment | Human Primary Cells |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Human Primary Cells, Animal Primary Cells |
Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Lonza Group Ltd, PromoCell GmbH, ZenBio, STEMCELL Technologies, Axol Bioscience |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to primary cells market will help companies and investors design strategic landscapes.
Human primary cells was the largest segment with a revenue share of 63.38% in 2023. Horizon Databook has segmented the Australia primary cells market based on human primary cells, animal primary cells covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia primary cells market , including forecasts for subscribers. This country databook contains high-level insights into Australia primary cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account